Cleveland Diagnostics
Share
Greetings from ! Our team has arrived in Washington, DC, and we are looking forward to connecting with the urology community.
Visit us at booth #4111 to discuss the evolving landscape of prostate cancer detection and learn how the IsoPSA Test can support more confident risk stratification and biopsy decision-making.
Join us at AUA 2026 in Washington, DC, and visit our booth ( #4111) to connect with our team.
As you know, PSA is a valuable screening tool, but it lacks specificity. The results may not allow clinicians to distinguish clinically significant prostate cancer (csPCa) from benign conditions like prostatitis, inflammation, or BPH.
The IsoPSA Test is different. It’s designed to improve specificity, enhance MRI results, and provide insight into a patient’s risk of csPCa over the next 30 months.
To learn more, stop by booth #4111 or go to https://hubs.la/Q04c9tPP0.
04/23/2026
This Medical Laboratory Professionals Week , we are celebrating and recognizing the critical role our laboratory team plays in delivering diagnostic insights to patients and clinicians nationwide.
Their expertise and commitment to excellence ensure that every test result is reliable and accurate.
Thank you to our lab team for the vital work you do every day to support better patient care!
Click here to claim your Sponsored Listing.
